Cardiovascular Toxicities Associated with Cancer Immunotherapies.
about
Smoldering myocarditis following immune checkpoint blockade.Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer.Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.Cardiotoxicity of Anticancer Therapeutics.Identifying and managing the adverse effects of immune checkpoint blockade.Cardiotoxicity of immune checkpoint inhibitors.Immune Checkpoint Inhibitor-Related Cardiotoxicity
P2860
Q47105402-75C3A083-D43E-4C44-99A1-8E109AD1EA7DQ47162183-D70B1C84-35E2-4D3B-BC62-37D59B4FB909Q47224948-366FFD3B-07A8-49B6-B0CC-15DBCA2B5582Q49315568-3D70351C-DE87-465E-AA00-F096F13BB929Q50326869-0EB1550D-7010-4736-89D3-6A90ABCE7D3CQ55409972-643DAED5-38C5-4D3D-9050-5ADA296CA01DQ55438414-56252005-FB7F-466B-AA3D-B3F9A5B9A03DQ58571002-6EBE1789-0B20-4AA0-A2B9-2A67740DA9D1
P2860
Cardiovascular Toxicities Associated with Cancer Immunotherapies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Cardiovascular Toxicities Associated with Cancer Immunotherapies.
@en
Cardiovascular Toxicities Associated with Cancer Immunotherapies.
@nl
type
label
Cardiovascular Toxicities Associated with Cancer Immunotherapies.
@en
Cardiovascular Toxicities Associated with Cancer Immunotherapies.
@nl
prefLabel
Cardiovascular Toxicities Associated with Cancer Immunotherapies.
@en
Cardiovascular Toxicities Associated with Cancer Immunotherapies.
@nl
P2093
P2860
P1476
Cardiovascular Toxicities Associated with Cancer Immunotherapies.
@en
P2093
Daniel Y Wang
Douglas B Johnson
Javid J Moslehi
Thomas G Neilan
P2860
P2888
P356
10.1007/S11886-017-0835-0
P577
2017-03-01T00:00:00Z